ArticleEuropean journal of gastroenterology & hepatology2020

Increased neuroendocrine tumours, but small colorectal cancer incidence in patients with inflammatory bowel disease treated by mesalazine.

Metin Basaranoğlu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.